Genes modulated by 2ME2 in MM cells
| Gene name . | GenBank no. . | 2ME2 (fold change over control) . | ||||
|---|---|---|---|---|---|---|
| 6 hr . | 12 hr . | 24 hr . | 48 hr . | 72 hr . | ||
| Growth/proliferation and cell adhesion | ||||||
| Interleukin 2 receptor, γ | D11086 | −1.8 | −1.8 | −2.1 | −3.0 | −2.5 |
| BTG family, member 2 | U72649 | −1.8 | −1.9 | −2.4 | −2.9 | −1.9 |
| Small inducible cytokine A3 | D90144 | −1.5 | −1.4 | −1.7 | −2.4 | 1.5 |
| Rho GDP dissociation inhibitor (GDI) | X69549 | −2.0 | −1.9 | −1.5 | −1.6 | −2.5 |
| G-protein coupled receptor | AF091890 | 1.3 | 2.6 | 1.2 | 1.3 | 1.3 |
| Mucin 1, transmembrane | X52228 | 2.1 | 1.5 | 1.6 | 1.5 | 1.8 |
| Integrin, β 5 | M35011 | 1.5 | 2.5 | 1.5 | 1.6 | 1.3 |
| LPS-induced TNF-α factor | AF010312 | −3.1 | −3.6 | −2.8 | −2.9 | −2.3 |
| TNF-α–induced protein 3 | M59465 | −2.3 | −2.0 | −2.8 | −3.0 | −2.6 |
| Antigen identified by monoclonal antibody Ki-67 | X65550 | −2.6 | −2.3 | −1.2 | −1.7 | −2.1 |
| Farnesyl diphosphate synthase | D14697 | −2.3 | −2.2 | −1.8 | −1.7 | −1.7 |
| Apoptosis/survival/drug resistance | ||||||
| Proline dehydrogenase (oxidase) 1 | U82381 | 2.8 | 2.1 | 2.4 | 2.1 | 2.2 |
| Creatine kinase | X15334 | 2.9 | 1.8 | 1.5 | 1.3 | 1.4 |
| Poly (ADP-ribose) polymerase | J03473 | −1.4 | −1.7 | −1.7 | −1.6 | −1.9 |
| Crystalin, β B1 | U35340 | 2.5 | 2.1 | 1.3 | 1.7 | 1.5 |
| C-myc-P64 | M13929 | 2.5 | 2.4 | 1.8 | 1.6 | 1.1 |
| Casein kinase 1, epsilon | L37043 | −2.1 | −1.7 | −1.8 | −1.7 | −1.9 |
| NM23/nonmetastatic cells 4 | Y07604 | −2.1 | −1.9 | −2.2 | −2.3 | −2.8 |
| C-terminal binding protein 1 | U37408 | −2.2 | −2.5 | −2.4 | −3.4 | −2.8 |
| Pyruvate kinase | M26252 | −3.4 | −4.6 | −3.1 | −5.0 | −6.1 |
| CDC28 protein kinase 2 | X54942 | −1.6 | −1.6 | 1.5 | 2.5 | 1.4 |
| Protein tyrosine phosphatase, nonreceptor type 6 | X62055 | −3.5 | −3.3 | −2.5 | −2.8 | −2.3 |
| Lectin, galactoside-binding, soluble, 1 (galactin 1) | AI535946 | −2.5 | −2.8 | −3.1 | −1.9 | −2.3 |
| V-raf-1 murine leukemia viral oncogene homolog 1 | X06409 | −2.5 | −3.1 | −2.5 | −2.2 | −1.8 |
| Myeloid cell leukemia sequence 1 (BCL2 related) | L08246 | −2.2 | −2.1 | −2.2 | −2.4 | −1.9 |
| Adrenomedullin | D14874 | −2.4 | −2.6 | −3.2 | −4.8 | −6.4 |
| X-box binding protein 1 | Z93930 | −1.9 | −2.4 | −2.5 | −3.2 | −1.8 |
| Pim-2oncogene | U77735 | −1.5 | −1.3 | −1.4 | −2.3 | −2.0 |
| Endoplasmic reticulum and translation | ||||||
| Eukaryotic translation initiation factor 5A | AI074025 | 2.0 | 1.6 | 2.1 | 1.5 | 1.4 |
| Eukaryotic translation initiation factor 4B | X55733 | −2.8 | −2.7 | −2.8 | −3.1 | −2.6 |
| Eukaryotic translation elongation factor 1 | L41498 | −2.0 | −2.3 | −2.2 | −2.1 | −1.0 |
| Eukaryotic translation initiation factor 3 | U94855 | −2.3 | −2.3 | −1.6 | −1.5 | −1.7 |
| TAP binding protein (tapasin) | AF029750 | −2.2 | −2.8 | −2.6 | −3.0 | −1.9 |
| Tumor rejection antigen (gp96) | X15187 | −1.9 | −2.4 | −2.4 | −2.3 | −1.4 |
| Endoplasmic reticulum stress inducible | AF055001 | −1.5 | −2.2 | −2.4 | −2.0 | 1.2 |
| Cytoskeleton/structural | ||||||
| Suppression of tumorigenicity 5 | U15131 | 2.0 | 2.1 | 1.6 | 1.7 | 1.6 |
| Tubulin, β, 2 | X02344 | −1.9 | −2.4 | −1.3 | −1.5 | −2.4 |
| Actin-related protein 2/3 complex | AF006088 | −1.2 | −1.5 | −2.6 | −1.3 | −1.5 |
| Vimentin | Z19554 | −2.1 | −2.9 | −1.7 | −1.4 | −1.4 |
| Lymphocyte specific protein 1 | M33552 | −4.0 | −4.2 | −2.7 | −2.6 | −2.2 |
| Adducin 1 (α) | X58141 | −1.7 | −1.8 | −2.2 | −2.3 | −1.9 |
| Ubiquitins and metabolism | ||||||
| Nucleosome assembly protein 1-like 1 | W26056 | −1.9 | −2.5 | −2.3 | −2.3 | −2.0 |
| γ-glutamyltransferase 2 | M30474 | −2.0 | −2.5 | −1.4 | −1.8 | −1.3 |
| Phosphomannomutase 2 | U85773 | 2.4 | 1.9 | 1.4 | 1.7 | 1.5 |
| Ubiquitin-conjugating enzyme E2M | AF075599 | 2.2 | 2.1 | 2.6 | 2.4 | 2.0 |
| Karyopherin α 2 (RAG) | U28386 | −1.1 | −1.2 | 1.2 | 1.2 | −2.1 |
| Solute carrier family 25 | J03592 | −2.6 | −2.7 | −2.1 | −1.9 | −1.5 |
| Cytochrome c oxidase subunit VIa polypeptide 1 | AI540925 | −1.6 | −1.8 | −1.3 | −1.2 | −1.3 |
| Ubiquitin-conjugating enzyme E2G 2 | AF032456 | 1.7 | 1.7 | 1.1 | 1.8 | 1.1 |
| Ubiquitin-conjugating enzyme E2E 3 | AB017644 | −1.6 | −1.6 | −1.8 | −1.6 | −1.9 |
| Splicing factor, arginine/serine-rich 6 | AL031681 | 2.0 | 1.5 | −1.0 | −1.2 | −1.1 |
| Leukotriene A4 hydrolase | J03459 | −2.4 | −2.4 | −2.0 | −2.8 | −2.1 |
| Ubiquitin-activating enzyme E1 | M58028 | −2.2 | −2.8 | −2.2 | −2.6 | −2.0 |
| FK506 binding protein 1A (12 kDa) | V00599 | −2.1 | −1.9 | −1.5 | −2.9 | −4.5 |
| RNA binding motif protein 3 | U28686 | 1.8 | 2.1 | 1.6 | 1.5 | 1.4 |
| Gene name . | GenBank no. . | 2ME2 (fold change over control) . | ||||
|---|---|---|---|---|---|---|
| 6 hr . | 12 hr . | 24 hr . | 48 hr . | 72 hr . | ||
| Growth/proliferation and cell adhesion | ||||||
| Interleukin 2 receptor, γ | D11086 | −1.8 | −1.8 | −2.1 | −3.0 | −2.5 |
| BTG family, member 2 | U72649 | −1.8 | −1.9 | −2.4 | −2.9 | −1.9 |
| Small inducible cytokine A3 | D90144 | −1.5 | −1.4 | −1.7 | −2.4 | 1.5 |
| Rho GDP dissociation inhibitor (GDI) | X69549 | −2.0 | −1.9 | −1.5 | −1.6 | −2.5 |
| G-protein coupled receptor | AF091890 | 1.3 | 2.6 | 1.2 | 1.3 | 1.3 |
| Mucin 1, transmembrane | X52228 | 2.1 | 1.5 | 1.6 | 1.5 | 1.8 |
| Integrin, β 5 | M35011 | 1.5 | 2.5 | 1.5 | 1.6 | 1.3 |
| LPS-induced TNF-α factor | AF010312 | −3.1 | −3.6 | −2.8 | −2.9 | −2.3 |
| TNF-α–induced protein 3 | M59465 | −2.3 | −2.0 | −2.8 | −3.0 | −2.6 |
| Antigen identified by monoclonal antibody Ki-67 | X65550 | −2.6 | −2.3 | −1.2 | −1.7 | −2.1 |
| Farnesyl diphosphate synthase | D14697 | −2.3 | −2.2 | −1.8 | −1.7 | −1.7 |
| Apoptosis/survival/drug resistance | ||||||
| Proline dehydrogenase (oxidase) 1 | U82381 | 2.8 | 2.1 | 2.4 | 2.1 | 2.2 |
| Creatine kinase | X15334 | 2.9 | 1.8 | 1.5 | 1.3 | 1.4 |
| Poly (ADP-ribose) polymerase | J03473 | −1.4 | −1.7 | −1.7 | −1.6 | −1.9 |
| Crystalin, β B1 | U35340 | 2.5 | 2.1 | 1.3 | 1.7 | 1.5 |
| C-myc-P64 | M13929 | 2.5 | 2.4 | 1.8 | 1.6 | 1.1 |
| Casein kinase 1, epsilon | L37043 | −2.1 | −1.7 | −1.8 | −1.7 | −1.9 |
| NM23/nonmetastatic cells 4 | Y07604 | −2.1 | −1.9 | −2.2 | −2.3 | −2.8 |
| C-terminal binding protein 1 | U37408 | −2.2 | −2.5 | −2.4 | −3.4 | −2.8 |
| Pyruvate kinase | M26252 | −3.4 | −4.6 | −3.1 | −5.0 | −6.1 |
| CDC28 protein kinase 2 | X54942 | −1.6 | −1.6 | 1.5 | 2.5 | 1.4 |
| Protein tyrosine phosphatase, nonreceptor type 6 | X62055 | −3.5 | −3.3 | −2.5 | −2.8 | −2.3 |
| Lectin, galactoside-binding, soluble, 1 (galactin 1) | AI535946 | −2.5 | −2.8 | −3.1 | −1.9 | −2.3 |
| V-raf-1 murine leukemia viral oncogene homolog 1 | X06409 | −2.5 | −3.1 | −2.5 | −2.2 | −1.8 |
| Myeloid cell leukemia sequence 1 (BCL2 related) | L08246 | −2.2 | −2.1 | −2.2 | −2.4 | −1.9 |
| Adrenomedullin | D14874 | −2.4 | −2.6 | −3.2 | −4.8 | −6.4 |
| X-box binding protein 1 | Z93930 | −1.9 | −2.4 | −2.5 | −3.2 | −1.8 |
| Pim-2oncogene | U77735 | −1.5 | −1.3 | −1.4 | −2.3 | −2.0 |
| Endoplasmic reticulum and translation | ||||||
| Eukaryotic translation initiation factor 5A | AI074025 | 2.0 | 1.6 | 2.1 | 1.5 | 1.4 |
| Eukaryotic translation initiation factor 4B | X55733 | −2.8 | −2.7 | −2.8 | −3.1 | −2.6 |
| Eukaryotic translation elongation factor 1 | L41498 | −2.0 | −2.3 | −2.2 | −2.1 | −1.0 |
| Eukaryotic translation initiation factor 3 | U94855 | −2.3 | −2.3 | −1.6 | −1.5 | −1.7 |
| TAP binding protein (tapasin) | AF029750 | −2.2 | −2.8 | −2.6 | −3.0 | −1.9 |
| Tumor rejection antigen (gp96) | X15187 | −1.9 | −2.4 | −2.4 | −2.3 | −1.4 |
| Endoplasmic reticulum stress inducible | AF055001 | −1.5 | −2.2 | −2.4 | −2.0 | 1.2 |
| Cytoskeleton/structural | ||||||
| Suppression of tumorigenicity 5 | U15131 | 2.0 | 2.1 | 1.6 | 1.7 | 1.6 |
| Tubulin, β, 2 | X02344 | −1.9 | −2.4 | −1.3 | −1.5 | −2.4 |
| Actin-related protein 2/3 complex | AF006088 | −1.2 | −1.5 | −2.6 | −1.3 | −1.5 |
| Vimentin | Z19554 | −2.1 | −2.9 | −1.7 | −1.4 | −1.4 |
| Lymphocyte specific protein 1 | M33552 | −4.0 | −4.2 | −2.7 | −2.6 | −2.2 |
| Adducin 1 (α) | X58141 | −1.7 | −1.8 | −2.2 | −2.3 | −1.9 |
| Ubiquitins and metabolism | ||||||
| Nucleosome assembly protein 1-like 1 | W26056 | −1.9 | −2.5 | −2.3 | −2.3 | −2.0 |
| γ-glutamyltransferase 2 | M30474 | −2.0 | −2.5 | −1.4 | −1.8 | −1.3 |
| Phosphomannomutase 2 | U85773 | 2.4 | 1.9 | 1.4 | 1.7 | 1.5 |
| Ubiquitin-conjugating enzyme E2M | AF075599 | 2.2 | 2.1 | 2.6 | 2.4 | 2.0 |
| Karyopherin α 2 (RAG) | U28386 | −1.1 | −1.2 | 1.2 | 1.2 | −2.1 |
| Solute carrier family 25 | J03592 | −2.6 | −2.7 | −2.1 | −1.9 | −1.5 |
| Cytochrome c oxidase subunit VIa polypeptide 1 | AI540925 | −1.6 | −1.8 | −1.3 | −1.2 | −1.3 |
| Ubiquitin-conjugating enzyme E2G 2 | AF032456 | 1.7 | 1.7 | 1.1 | 1.8 | 1.1 |
| Ubiquitin-conjugating enzyme E2E 3 | AB017644 | −1.6 | −1.6 | −1.8 | −1.6 | −1.9 |
| Splicing factor, arginine/serine-rich 6 | AL031681 | 2.0 | 1.5 | −1.0 | −1.2 | −1.1 |
| Leukotriene A4 hydrolase | J03459 | −2.4 | −2.4 | −2.0 | −2.8 | −2.1 |
| Ubiquitin-activating enzyme E1 | M58028 | −2.2 | −2.8 | −2.2 | −2.6 | −2.0 |
| FK506 binding protein 1A (12 kDa) | V00599 | −2.1 | −1.9 | −1.5 | −2.9 | −4.5 |
| RNA binding motif protein 3 | U28686 | 1.8 | 2.1 | 1.6 | 1.5 | 1.4 |
List of genes selected from Figures 1 and 2 with their potential functional categories. Fold changes shown represent the ratio of gene expression in 2ME2-treated cells versus untreated MM.1S MM cells. The gene expression values were obtained using DChip.